Our research themes include:
Rare diseases
- recruiting cohorts of patients for genetic analyses
 - developing methods to assess high throughput genomic data
 - understanding how epigenetic changes and epigenetic regulation contribute to rare and complex disorders
 
Cancer
- detection of patterns of large and small scale somatic changes in the genome that give rise to cancers such as myeloid and peritoneal malignancies
 - understanding how inherited variation increases risk to various cancers (breast, blood) and myeloid malignancies
 
Bioinformatics
- programming, software and statistical techniques to analyse and integrate large-scale genetic datasets including next generation sequencing (NGS/WES/WGS/RNAseq), genome-wide association studies (GWAS), polygenic risk scores (PRS), Mendelian randomisation, network analyses, and machine learning
 - developing and maintaining informatic pipelines to process, curate and interpret high throughput healthcare data
 
Population genetics and statistics
- large cohort analyses (for example Genomics England, UKBioBank etc)
 
Functional Genomics
- translational value of parallel short and long read DNA and RNA sequencing
 - modelling genetic variants of uncertain significance in model systems
 - understanding the complex interaction of the epithelial barrier with environmental challenges using 3D in vitro and tissue engineering models
 
Pharmacogenomics
- understanding how changes in DNA alter our response to therapeutic drugs
 
Multiomics
- using artificial intelligence to uncover cryptic patterns in data
 
Disease areas
- promoting patient and population health is at the core of our research. We apply our research methods across a wide range of human diseases where a genetic basis is suspected but not well understood in order to improve diagnoses, predicting outcomes or informing best clinical interventions; these include very rare diseases without a genetic diagnosis, growth failure or abnormal growth syndromes, neurodevelopmental disorders, renal and ophthalmic diseases, aneurysmal subarachnoid haemorrhage as well as more common autoimmune disorders.
 
Current diseases and cohorts
These include:
- young onset breast cancer (POSH)
 - aneurysmal subarachnoid haemorrhage (aSAH, HATCH consortium)
 - soft tissue sarcomas (rhabdomyosarcoma and liposarcoma)
 - neuroblastoma
 - pancreatic cancer and myeloid cancers (CML, MPN/MDS)
 - splicing and disease
 - inflammatory bowel disease